Hyperbaric oxygen and aerobic exercise in the long-term treatment of fibromyalgia: A narrative review.
Kholoud M El-Shewy, Ahmad Kunbaz, Mohamed M Gad...
https://pubmed.ncbi.nlm.nih.gov/30399600/Actively Recruiting
Led by University Hospital Ostrava · Updated on 2026-08-25
60
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are evaluating hyperbaric oxygen therapy HBOT as an additional treatment for severe complex regional pain syndrome CRPS in adults. This randomized controlled trial uses a delayed-start design to compare immediate versus delayed HBOT effects. The primary comparison occurs 4-6 weeks after the baseline, with further evaluation of the delayed group after their treatment begins. The study is sponsored by University Hospital Ostrava and aims to understand HBOTs role in managing CRPS symptoms and function. Participants are divided into two groups the early group receives HBOT immediately following the baseline assessment, undergoing 20-30 sessions over 4-6 weeks. The delayed group receives usual care during the first 4-6 weeks and then crosses over to receive the same HBOT regimen. This crossover design allows comparison between immediate and delayed treatment effects on CRPS. During the study, participants undergo functional tests such as active wrist range of motion and WHODAS 2.0 assessments at baseline and follow-up visits. Researchers also measure pain intensity, pain responder status, CRPS severity, quality of life, and patient global impression of change. These evaluations occur at scheduled intervals to monitor treatment impact. The study continues until April 2029, including primary outcome measurement and ongoing participant monitoring.
CONDITIONS
Hyperbaric Oxygen Therapy in Complex Regional Pain Syndrome
M
Michal Hájek, MD, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital Ostrava
Lead Sponsor
Municipal Hospital Ostrava Fifejdy
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 to 6 weeks
Participants receive hyperbaric oxygen therapy sessions either immediately after baseline or after a 4-6 week delay, depending on their group assignment.
20 to 30 therapy sessions over this period
Duration - 4 to 6 weeks
Participants are evaluated after therapy completion to assess functional outcomes and symptom changes.
1 follow-up visit after treatment
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Kholoud M El-Shewy, Ahmad Kunbaz, Mohamed M Gad...
https://pubmed.ncbi.nlm.nih.gov/30399600/J David Clark, Vivianne L Tawfik, Maral Tajerian...
https://pubmed.ncbi.nlm.nih.gov/30124090/A M Elliott, B H Smith, K I Penny...
https://pubmed.ncbi.nlm.nih.gov/10520633/Adley Tsang, Michael Von Korff, Sing Lee...
https://pubmed.ncbi.nlm.nih.gov/18602869/P P Sarangi, A J Ward, E J Smith...
https://pubmed.ncbi.nlm.nih.gov/8496220/Michael d'A Stanton-Hicks
https://pubmed.ncbi.nlm.nih.gov/30777902/Stephen Bruehl
https://pubmed.ncbi.nlm.nih.gov/26224572/Lone F Knudsen, Astrid J Terkelsen, Peter D Drummond...
https://pubmed.ncbi.nlm.nih.gov/31104164/J V Olander, J C Marasa, R C Kimes...
https://pubmed.ncbi.nlm.nih.gov/7084977/Neil E O'Connell, Benedict M Wand, James McAuley...
https://pubmed.ncbi.nlm.nih.gov/23633371/University Hospital Ostrava
Lead Sponsor
Municipal Hospital Ostrava Fifejdy
Collaborating Sponsor